Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.43 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3725050 | 0.91 | CYP4F2 (0.47) | CYP4F2CYP4A11NPSR1 | |
| SCHEMBL6730542 | 0.88 | CYP3A4 (0.35) | CYP4F2CYP4A11NPSR1 | |
| SCHEMBL6358085 | 0.84 | CYP2D6 (0.42) | — | |
| SCHEMBL31674175 | 0.79 | CYP4F2 (0.46) | CYP4F2CYP4A11NPSR1LMNA | |
| SCHEMBL6735060 | 0.74 | SMN1; SMN2 (0.38) | LMNA | |
| SCHEMBL21987144 | 0.73 | — | — | |
| SCHEMBL7364717 | 0.73 | CYP4F2 (0.38) | CYP4F2CYP4A11 | |
| SCHEMBL7254072 | 0.72 | ALDH1A1 (0.38) | — | |
| SCHEMBL15572899 | 0.72 | CYP4F2 (0.51) | CYP4F2CYP4A11NPSR1LMNA | |
| SCHEMBL1503918 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100292251-A1 | MONTELUKAST BENZHYDRYL PIPERAZINE SALTS AND PROCESS FOR PREPARATION THEREOF | TORRENT PHARMACEUTICALS LIMITED (IN) | 2010-11-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100292251-A1 | MONTELUKAST BENZHYDRYL PIPERAZINE SALTS AND PROCESS FOR PREPARATION THEREOF | CMA1, CYSLTR2, CYSLTR1 | CYP4F2 781/4885CYP4A11 536/4885NPSR1 1973/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.